Universe Pharmaceuticals INC (UPC)

NASDAQ: UPC · USD

$1.49

+0.02 (+1.4%)· Recorded snapshot

Market cap	7.5M
Revenue (ttm)	17.7M
Net income (ttm)	-1.9M
EPS (ttm)	-$3.45
Shares out	5M
Volume	173,647.718
Beta	1.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.7M
Net income (ttm): -1.9M
EPS (ttm): -$3.45
Market cap: 7.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.5

P25 n/aP50 n/aP75 n/a

ROIC-5.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All UPC indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001809616
Company name	Universe Pharmaceuticals INC
Country	China
Country code	US
CUSIP number	G9442G138
Earnings date	2026-01-29
Earnings time	amc
Employees	216
Employees change	-9
Employees growth	-4%
Enterprise value	$-12M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-03-31
First seen	2026-05-09
Fiscal year end	September
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2021-03-23
Is primary listing	Yes
Is SPAC	No
ISIN number	KYG9442G1385
Last 10-K release date	2026-01-29
Last earnings date	2026-01-29
Last refreshed	2026-11-04
Last stock split date	2025-03-24
Last stock split type	Reverse
Market cap	$7.5M
Market cap category	Nano-Cap
Next earnings date	2027-01-28
Options	No
Price	$1.49
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	UPC
Website	https://www.universe-pharmacy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-231.26%
FCF / EV yield	103.19%
FCF yield	-165.54%
Industry forward P/E	14.04x
Industry P/E	107.82x
P/B ratio	0.02x
P/S ratio	0.42x
Price / tangible book value	0.14x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-11.78%
EBITDA margin	-9.08%
Gross margin	36.52%
Operating margin	-11.78%
Pretax margin	-10.95%
Profit margin	-10.95%
Profit per employee	$-8,991
Revenue per employee	$82,139
ROA	-1.72%
ROA (5Y)	-1.26%
ROCE	-3.61%
ROE	-3.5%
ROE (5Y)	-7.06%
ROIC	-5.78%
ROIC (5Y)	-6.54%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	10.43%
Gross profit growth (Q)	-0.8%
Gross profit growth 3Y	-23.13%
Gross profit growth 5Y	-18.08%
Net income growth years	1
Revenue growth	-8.04%
Revenue growth (Q)	-1.28%
Revenue growth (QoQ)	3.79%
Revenue growth 3Y	-19.81%
Revenue growth 5Y	-14.4%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-481,019
Depreciation and amortization	$479,009
EBIT	$-2.1M
EBITDA	$-1.6M
EPS	$-3.45
FCF per share	$-2.47
Financing cash flow	$-6.8M
Free cash flow	$-12.4M
Gross profit	$6.5M
Investing cash flow	$-2M
Net borrowing	$-6.8M
Net cash flow	$-19.7M
Net income	$-1.9M
Operating income	$-2.1M
Revenue	$17.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.67
Book value per share	$98.78
Debt / equity	0.17
Interest coverage	-7.28
Long-term assets	$16.3M
Long-term liabilities	$2.2M
Net cash (debt)	$19.5M
Net cash / market cap	260.43%
Net cash growth	299.54%
Net debt / equity	-0.35
Piotroski F-Score	2
Property, plant and equipment	$3.8M
Shareholders' equity	$55.6M
Tangible book value	$55.3M
Tangible book value per share	$98.23
Total assets	$71.5M
Total cash	$29M
Total debt	$9.6M
Total liabilities	$15.8M
WACC	7.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.23
Current assets	$55.2M
Current liabilities	$13.6M
Current ratio	4.05
Inventory turnover	2.98
Net working capital	$19.9M
Quick ratio	3.25
Working capital	$41.6M
Working capital turnover	0.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-205.01%
Dividend yield	0%
Shareholder yield	-205.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$4.00
1D price change	1.36%
1M price change	-66.89%
1M total return	-66.89%
1W price change	-33.48%
1W total return	-33.48%
1Y price change	-68.43%
1Y return CAGR	-68.46%
1Y total return	-68.43%
20-day SMA	$3.33
200-day SMA	$3.79
3M price change	-52.85%
3M total return	-52.85%
3Y price change	-99.78%
3Y return CAGR	-86.92%
3Y total return	-99.78%
50-day SMA	$4.07
50-day SMA vs 200-day SMA	50over200
52-week high	$17.96
52-week high date	2026-06-29
52-week low	$1.43
52-week low date	2026-11-02
5Y price change	-99.98%
5Y return CAGR	-82.3%
5Y total return	-99.98%
6M price change	-53.58%
6M total return	-53.58%
After-hours change	2.34%
After-hours close	$1.49
After-hours price	$1.52
All-time high	$43,163.97
All-time high date	2021-03-29
All-time low	$1.43
All-time low date	2026-11-02
Average true range (ATR)	$0.47
Average volume	186.9K
Beta (1Y)	6.15
Beta (2Y)	3.23
Beta (5Y)	1.85
Change from 52-week high	-91.7%
Change from 52-week low	4.2%
Change from all-time high	-100%
Change from all-time low	4.2%
Change from open	-0.67%
Day's gap	2.04%
Dollar volume	$258,735
High price	$1.67
Low price	$1.45
Monthly RSI	30.53
Open price	$1.50
Position in 52-week range	18.18%
Premarket change	-2.01%
Premarket close	$1.49
Premarket price	$1.46
Previous close	$1.47
Price vs 150-day SMA	-62.7%
Price vs 20-day SMA	-55.2%
Price vs 200-day SMA	-60.64%
Price vs 50-day SMA	-63.38%
Relative volume	0.93
Return from IPO open	-99.99%
Return from IPO price	-70.2%
RSI	22.58
Sharpe ratio	0.48
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	-0.03
Sortino ratio	1.79
Sortino ratio (3Y)	0.38
Sortino ratio (5Y)	-0.04
Volume	173.6K
Weekly RSI	34.4
YTD price change	-60.89%
YTD total return	-60.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	559.9K
Float percentage	11.14%
Shares change (QoQ)	-0.1%
Shares change (YoY)	205.01%
Shares held by insiders	88.86%
Shares held by institutions	1.4%
Shares outstanding	5M
Short % of float	5.41%
Short % of shares	0.6%
Short ratio	0.7 days

Deeper analysis on UPC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this UPC report

Is a complete UPC research report available?

No complete published report is available for Universe Pharmaceuticals INC (UPC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Universe Pharmaceuticals INC (UPC)

Price

Financial snapshot

Fair-value bridge

Latest news · UPC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All UPC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on UPC

Frequently asked questions